Engineered BDNF producing cells as a potential treatment for neurologic disease

Area of Science:

• Neuroscience
• Regenerative Medicine
• Cell Therapy

Background:

• Brain-derived neurotrophic factor (BDNF) is essential for neuronal survival, development, and synaptic plasticity.
• BDNF dysfunction is linked to various neurological diseases and injuries, highlighting its therapeutic potential.
• Restoring or enhancing BDNF levels is a key strategy in treating neurological conditions.

Purpose of the Study:

• To review the mechanisms of BDNF action.
• To discuss current BDNF therapies and delivery challenges.
• To explore mesenchymal stem cells (MSCs) as a novel delivery platform for BDNF.

Main Methods:

• Literature review focusing on BDNF mechanisms, therapies, and delivery systems.
• Analysis of studies investigating BDNF's role in neurological disease models.
• Evaluation of MSCs as a cell-based delivery vehicle for neurotrophic factors.

Main Results:

• BDNF plays a critical role in neuronal health and is implicated in numerous neurological disorders.
• Clinical translation of BDNF therapies is hindered by delivery challenges to the central nervous system.
• Engineered MSCs present a viable solution for targeted and effective BDNF delivery.

Conclusions:

• BDNF is a vital neurotrophic factor with significant therapeutic potential for neurological diseases.
• Overcoming delivery obstacles is crucial for advancing BDNF-based treatments.
• Mesenchymal stem cell-based delivery systems show promise for future clinical applications of BDNF therapy.